Global Active Pharmaceutical Ingredients (API) Industry Market Report-Development Trends, Threats, Opportunities and Competitive Landscape in 2020
- Report Code : MAI2070086
- Published On: Oct, 2020
- Category : Chemicals & Materials
- Pages : 111
-
Any substance or mixture of substances intended for use in the manufacture of pharmaceuticals, and when used in pharmaceuticals, becomes an active ingredient of pharmaceuticals. Such substances may have pharmacological activity or other direct effects in the diagnosis, treatment, symptom relief, treatment or prevention of the disease, or may affect the function or structure of the body.
The Active Pharmaceutical Ingredients (API) market revenue was xx.xx Million USD in 2019, and will reach xx.xx Million USD in 2025, with a CAGR of x.x% during 2020-2025.
Under COVID-19 outbreak globally, this report provides 360 degrees of analysis from supply chain, import and export control to regional government policy and future influence on the industry. Detailed analysis about market status (2015-2020), enterprise competition pattern, advantages and disadvantages of enterprise products, industry development trends (2020-2025), regional industrial layout characteristics and macroeconomic policies, industrial policy has also been included. From raw materials to end users of this industry are analyzed scientifically, the trends of product circulation and sales channel will be presented as well. Considering COVID-19, this report provides comprehensive and in-depth analysis on how the epidemic push this industry transformation and reform.
In COVID-19 outbreak, Chapter 2.2 of this report provides an analysis of the impact of COVID-19 on the global economy and the Active Pharmaceutical Ingredients (API) industry.
Chapter 3.7 covers the analysis of the impact of COVID-19 from the perspective of the industry chain.
In addition, chapters 7-11 consider the impact of COVID-19 on the regional economy.
The Active Pharmaceutical Ingredients (API) market can be split based on product types, major applications, and important countries as follows:
Key players in the global Active Pharmaceutical Ingredients (API) market covered in Chapter 12:
Teva Pharmaceutical Industries LTD
BASF SE
Pfizer, Inc.
Dr. Reddy's Laboratories
Mylan N.V.
Boehringer Ingelheim GmbH
Albemarle Corporation
Hospira Inc.
Lonza Group
Actavis plc
Lupin Pharmaceuticals Inc.
Novartis AG
Aurobindo Pharma Limited
Sun Pharmaceutical Industries LTD
Fresenius Kabi
In Chapter 4 and 14.1, on the basis of types, the Active Pharmaceutical Ingredients (API) market from 2015 to 2025 is primarily split into:
Synthetic Chemical API
Biological API
In Chapter 5 and 14.2, on the basis of applications, the Active Pharmaceutical Ingredients (API) market from 2015 to 2025 covers:
Anti-infectives
Oncology
Cardiovascular and hematopoietic system
Central nervous system
Respiratory system
Gastrointestinal
Hormonal related disorders
Metabolic disorders
Genito-urinary disorders
Musculo-skeletal disorders
Other Therapeutics Uses
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2015-2025) of the following regions are covered in Chapter 6, 7, 8, 9, 10, 11, 14:
North America (Covered in Chapter 7 and 14)
United States
Canada
Mexico
Europe (Covered in Chapter 8 and 14)
Germany
UK
France
Italy
Spain
Russia
Others
Asia-Pacific (Covered in Chapter 9 and 14)
China
Japan
South Korea
Australia
India
Southeast Asia
Others
Middle East and Africa (Covered in Chapter 10 and 14)
Saudi Arabia
UAE
Egypt
Nigeria
South Africa
Others
South America (Covered in Chapter 11 and 14)
Brazil
Argentina
Columbia
Chile
Others
Years considered for this report:
Historical Years: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2020-2025
-
With tables and figures helping analyze worldwide Global Active Pharmaceutical Ingredients (API) market, this research provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.
Table of Content
1 Active Pharmaceutical Ingredients (API) Introduction and Market Overview1.1 Objectives of the Study
1.2 Overview of Active Pharmaceutical Ingredients (API)
1.3 Scope of The Study
1.3.1 Key Market Segments
1.3.2 Players Covered
1.3.3 COVID-19's impact on the Active Pharmaceutical Ingredients (API) industry1.4 Methodology of The Study
1.5 Research Data Source
2 Executive Summary2.1 Market Overview
2.1.1 Global Active Pharmaceutical Ingredients (API) Market Size, 2015 – 2020
2.1.2 Global Active Pharmaceutical Ingredients (API) Market Size by Type, 2015 – 2020
2.1.3 Global Active Pharmaceutical Ingredients (API) Market Size by Application, 2015 – 2020
2.1.4 Global Active Pharmaceutical Ingredients (API) Market Size by Region, 2015 - 20252.2 Business Environment Analysis
2.2.1 Global COVID-19 Status and Economic Overview
2.2.2 Influence of COVID-19 Outbreak on Active Pharmaceutical Ingredients (API) Industry Development
3 Industry Chain Analysis3.1 Upstream Raw Material Suppliers of Active Pharmaceutical Ingredients (API) Analysis
3.2 Major Players of Active Pharmaceutical Ingredients (API)
3.3 Active Pharmaceutical Ingredients (API) Manufacturing Cost Structure Analysis
3.3.1 Production Process Analysis
3.3.2 Manufacturing Cost Structure of Active Pharmaceutical Ingredients (API)
3.3.3 Labor Cost of Active Pharmaceutical Ingredients (API)3.4 Market Distributors of Active Pharmaceutical Ingredients (API)
3.5 Major Downstream Buyers of Active Pharmaceutical Ingredients (API) Analysis
3.6 The Impact of Covid-19 From the Perspective of Industry Chain
3.7 Regional Import and Export Controls Will Exist for a Long Time
3.8 Continued downward PMI Spreads Globally
4 Global Active Pharmaceutical Ingredients (API) Market, by Type4.1 Global Active Pharmaceutical Ingredients (API) Value and Market Share by Type (2015-2020)
4.2 Global Active Pharmaceutical Ingredients (API) Production and Market Share by Type (2015-2020)
4.3 Global Active Pharmaceutical Ingredients (API) Value and Growth Rate by Type (2015-2020)
4.3.1 Global Active Pharmaceutical Ingredients (API) Value and Growth Rate of Synthetic Chemical API
4.3.2 Global Active Pharmaceutical Ingredients (API) Value and Growth Rate of Biological API4.4 Global Active Pharmaceutical Ingredients (API) Price Analysis by Type (2015-2020)
5 Active Pharmaceutical Ingredients (API) Market, by Application5.1 Downstream Market Overview
5.2 Global Active Pharmaceutical Ingredients (API) Consumption and Market Share by Application (2015-2020)
5.3 Global Active Pharmaceutical Ingredients (API) Consumption and Growth Rate by Application (2015-2020)
5.3.1 Global Active Pharmaceutical Ingredients (API) Consumption and Growth Rate of Anti-infectives (2015-2020)
5.3.2 Global Active Pharmaceutical Ingredients (API) Consumption and Growth Rate of Oncology (2015-2020)
5.3.3 Global Active Pharmaceutical Ingredients (API) Consumption and Growth Rate of Cardiovascular and hematopoietic system (2015-2020)
5.3.4 Global Active Pharmaceutical Ingredients (API) Consumption and Growth Rate of Central nervous system (2015-2020)
5.3.5 Global Active Pharmaceutical Ingredients (API) Consumption and Growth Rate of Respiratory system (2015-2020)
5.3.6 Global Active Pharmaceutical Ingredients (API) Consumption and Growth Rate of Gastrointestinal (2015-2020)
5.3.7 Global Active Pharmaceutical Ingredients (API) Consumption and Growth Rate of Hormonal related disorders (2015-2020)
5.3.8 Global Active Pharmaceutical Ingredients (API) Consumption and Growth Rate of Metabolic disorders (2015-2020)
5.3.9 Global Active Pharmaceutical Ingredients (API) Consumption and Growth Rate of Genito-urinary disorders (2015-2020)
5.3.10 Global Active Pharmaceutical Ingredients (API) Consumption and Growth Rate of Musculo-skeletal disorders (2015-2020)
5.3.11 Global Active Pharmaceutical Ingredients (API) Consumption and Growth Rate of Other Therapeutics Uses (2015-2020)
6 Global Active Pharmaceutical Ingredients (API) Market Analysis by Regions6.1 Global Active Pharmaceutical Ingredients (API) Sales, Revenue and Market Share by Regions
6.1.1 Global Active Pharmaceutical Ingredients (API) Sales by Regions (2015-2020)
6.1.2 Global Active Pharmaceutical Ingredients (API) Revenue by Regions (2015-2020)6.2 North America Active Pharmaceutical Ingredients (API) Sales and Growth Rate (2015-2020)
6.3 Europe Active Pharmaceutical Ingredients (API) Sales and Growth Rate (2015-2020)
6.4 Asia-Pacific Active Pharmaceutical Ingredients (API) Sales and Growth Rate (2015-2020)
6.5 Middle East and Africa Active Pharmaceutical Ingredients (API) Sales and Growth Rate (2015-2020)
6.6 South America Active Pharmaceutical Ingredients (API) Sales and Growth Rate (2015-2020)
7 North America Active Pharmaceutical Ingredients (API) Market Analysis by Countries7.1 The Influence of COVID-19 on North America Market
7.2 North America Active Pharmaceutical Ingredients (API) Sales, Revenue and Market Share by Countries
7.2.1 North America Active Pharmaceutical Ingredients (API) Sales by Countries (2015-2020)
7.2.2 North America Active Pharmaceutical Ingredients (API) Revenue by Countries (2015-2020)7.3 United States Active Pharmaceutical Ingredients (API) Sales and Growth Rate (2015-2020)
7.4 Canada Active Pharmaceutical Ingredients (API) Sales and Growth Rate (2015-2020)
7.5 Mexico Active Pharmaceutical Ingredients (API) Sales and Growth Rate (2015-2020)
8 Europe Active Pharmaceutical Ingredients (API) Market Analysis by Countries8.1 The Influence of COVID-19 on Europe Market
8.2 Europe Active Pharmaceutical Ingredients (API) Sales, Revenue and Market Share by Countries
8.2.1 Europe Active Pharmaceutical Ingredients (API) Sales by Countries (2015-2020)
8.2.2 Europe Active Pharmaceutical Ingredients (API) Revenue by Countries (2015-2020)8.3 Germany Active Pharmaceutical Ingredients (API) Sales and Growth Rate (2015-2020)
8.4 UK Active Pharmaceutical Ingredients (API) Sales and Growth Rate (2015-2020)
8.5 France Active Pharmaceutical Ingredients (API) Sales and Growth Rate (2015-2020)
8.6 Italy Active Pharmaceutical Ingredients (API) Sales and Growth Rate (2015-2020)
8.7 Spain Active Pharmaceutical Ingredients (API) Sales and Growth Rate (2015-2020)
8.8 Russia Active Pharmaceutical Ingredients (API) Sales and Growth Rate (2015-2020)
9 Asia Pacific Active Pharmaceutical Ingredients (API) Market Analysis by Countries9.1 The Influence of COVID-19 on Asia Pacific Market
9.2 Asia Pacific Active Pharmaceutical Ingredients (API) Sales, Revenue and Market Share by Countries
9.2.1 Asia Pacific Active Pharmaceutical Ingredients (API) Sales by Countries (2015-2020)
9.2.2 Asia Pacific Active Pharmaceutical Ingredients (API) Revenue by Countries (2015-2020)9.3 China Active Pharmaceutical Ingredients (API) Sales and Growth Rate (2015-2020)
9.4 Japan Active Pharmaceutical Ingredients (API) Sales and Growth Rate (2015-2020)
9.5 South Korea Active Pharmaceutical Ingredients (API) Sales and Growth Rate (2015-2020)
9.6 India Active Pharmaceutical Ingredients (API) Sales and Growth Rate (2015-2020)
9.7 Southeast Asia Active Pharmaceutical Ingredients (API) Sales and Growth Rate (2015-2020)
9.8 Australia Active Pharmaceutical Ingredients (API) Sales and Growth Rate (2015-2020)
10 Middle East and Africa Active Pharmaceutical Ingredients (API) Market Analysis by Countries10.1 The Influence of COVID-19 on Middle East and Africa Market
10.2 Middle East and Africa Active Pharmaceutical Ingredients (API) Sales, Revenue and Market Share by Countries
10.2.1 Middle East and Africa Active Pharmaceutical Ingredients (API) Sales by Countries (2015-2020)
10.2.2 Middle East and Africa Active Pharmaceutical Ingredients (API) Revenue by Countries (2015-2020)10.3 Saudi Arabia Active Pharmaceutical Ingredients (API) Sales and Growth Rate (2015-2020)
10.4 UAE Active Pharmaceutical Ingredients (API) Sales and Growth Rate (2015-2020)
10.5 Egypt Active Pharmaceutical Ingredients (API) Sales and Growth Rate (2015-2020)
10.6 Nigeria Active Pharmaceutical Ingredients (API) Sales and Growth Rate (2015-2020)
10.7 South Africa Active Pharmaceutical Ingredients (API) Sales and Growth Rate (2015-2020)
11 South America Active Pharmaceutical Ingredients (API) Market Analysis by Countries11.1 The Influence of COVID-19 on Middle East and Africa Market
11.2 South America Active Pharmaceutical Ingredients (API) Sales, Revenue and Market Share by Countries
11.2.1 South America Active Pharmaceutical Ingredients (API) Sales by Countries (2015-2020)
11.2.2 South America Active Pharmaceutical Ingredients (API) Revenue by Countries (2015-2020)11.3 Brazil Active Pharmaceutical Ingredients (API) Sales and Growth Rate (2015-2020)
11.4 Argentina Active Pharmaceutical Ingredients (API) Sales and Growth Rate (2015-2020)
11.5 Columbia Active Pharmaceutical Ingredients (API) Sales and Growth Rate (2015-2020)
11.6 Chile Active Pharmaceutical Ingredients (API) Sales and Growth Rate (2015-2020)
12 Competitive Landscape12.1 Teva Pharmaceutical Industries LTD
12.1.1 Teva Pharmaceutical Industries LTD Basic Information
12.1.2 Active Pharmaceutical Ingredients (API) Product Introduction
12.1.3 Teva Pharmaceutical Industries LTD Production, Value, Price, Gross Margin 2015-202012.2 BASF SE
12.2.1 BASF SE Basic Information
12.2.2 Active Pharmaceutical Ingredients (API) Product Introduction
12.2.3 BASF SE Production, Value, Price, Gross Margin 2015-202012.3 Pfizer, Inc.
12.3.1 Pfizer, Inc. Basic Information
12.3.2 Active Pharmaceutical Ingredients (API) Product Introduction
12.3.3 Pfizer, Inc. Production, Value, Price, Gross Margin 2015-202012.4 Dr. Reddy's Laboratories
12.4.1 Dr. Reddy's Laboratories Basic Information
12.4.2 Active Pharmaceutical Ingredients (API) Product Introduction
12.4.3 Dr. Reddy's Laboratories Production, Value, Price, Gross Margin 2015-202012.5 Mylan N.V.
12.5.1 Mylan N.V. Basic Information
12.5.2 Active Pharmaceutical Ingredients (API) Product Introduction
12.5.3 Mylan N.V. Production, Value, Price, Gross Margin 2015-202012.6 Boehringer Ingelheim GmbH
12.6.1 Boehringer Ingelheim GmbH Basic Information
12.6.2 Active Pharmaceutical Ingredients (API) Product Introduction
12.6.3 Boehringer Ingelheim GmbH Production, Value, Price, Gross Margin 2015-2020
12.7 Albemarle Corporation
12.7.1 Albemarle Corporation Basic Information
12.7.2 Active Pharmaceutical Ingredients (API) Product Introduction
12.7.3 Albemarle Corporation Production, Value, Price, Gross Margin 2015-2020
12.8 Hospira Inc.
12.8.1 Hospira Inc. Basic Information
12.8.2 Active Pharmaceutical Ingredients (API) Product Introduction
12.8.3 Hospira Inc. Production, Value, Price, Gross Margin 2015-2020
12.9 Lonza Group
12.9.1 Lonza Group Basic Information
12.9.2 Active Pharmaceutical Ingredients (API) Product Introduction
12.9.3 Lonza Group Production, Value, Price, Gross Margin 2015-202012.10 Actavis plc
12.10.1 Actavis plc Basic Information
12.10.2 Active Pharmaceutical Ingredients (API) Product Introduction
12.10.3 Actavis plc Production, Value, Price, Gross Margin 2015-2020
12.11 Lupin Pharmaceuticals Inc.
12.11.1 Lupin Pharmaceuticals Inc. Basic Information
12.11.2 Active Pharmaceutical Ingredients (API) Product Introduction
12.11.3 Lupin Pharmaceuticals Inc. Production, Value, Price, Gross Margin 2015-2020
12.12 Novartis AG
12.12.1 Novartis AG Basic Information
12.12.2 Active Pharmaceutical Ingredients (API) Product Introduction
12.12.3 Novartis AG Production, Value, Price, Gross Margin 2015-2020
12.13 Aurobindo Pharma Limited
12.13.1 Aurobindo Pharma Limited Basic Information
12.13.2 Active Pharmaceutical Ingredients (API) Product Introduction
12.13.3 Aurobindo Pharma Limited Production, Value, Price, Gross Margin 2015-2020
12.14 Sun Pharmaceutical Industries LTD
12.14.1 Sun Pharmaceutical Industries LTD Basic Information
12.14.2 Active Pharmaceutical Ingredients (API) Product Introduction
12.14.3 Sun Pharmaceutical Industries LTD Production, Value, Price, Gross Margin 2015-2020
12.15 Fresenius Kabi
12.15.1 Fresenius Kabi Basic Information
12.15.2 Active Pharmaceutical Ingredients (API) Product Introduction
12.15.3 Fresenius Kabi Production, Value, Price, Gross Margin 2015-2020
13 Industry Outlook13.1 Market Driver Analysis
13.1.2 Market Restraints Analysis
13.1.3 Market Trends Analysis13.2 Merger, Acquisition and New Investment
13.3 News of Product Release
14 Global Active Pharmaceutical Ingredients (API) Market Forecast14.1 Global Active Pharmaceutical Ingredients (API) Market Value & Volume Forecast, by Type (2020-2025)
14.1.1 Synthetic Chemical API Market Value and Volume Forecast (2020-2025)
14.1.2 Biological API Market Value and Volume Forecast (2020-2025)14.2 Global Active Pharmaceutical Ingredients (API) Market Value & Volume Forecast, by Application (2020-2025)
14.2.1 Anti-infectives Market Value and Volume Forecast (2020-2025)
14.2.2 Oncology Market Value and Volume Forecast (2020-2025)
14.2.3 Cardiovascular and hematopoietic system Market Value and Volume Forecast (2020-2025)
14.2.4 Central nervous system Market Value and Volume Forecast (2020-2025)
14.2.5 Respiratory system Market Value and Volume Forecast (2020-2025)
14.2.6 Gastrointestinal Market Value and Volume Forecast (2020-2025)
14.2.7 Hormonal related disorders Market Value and Volume Forecast (2020-2025)
14.2.8 Metabolic disorders Market Value and Volume Forecast (2020-2025)
14.2.9 Genito-urinary disorders Market Value and Volume Forecast (2020-2025)
14.2.10 Musculo-skeletal disorders Market Value and Volume Forecast (2020-2025)
14.2.11 Other Therapeutics Uses Market Value and Volume Forecast (2020-2025)14.3 Active Pharmaceutical Ingredients (API) Market Analysis and Forecast by Region
14.3.1 North America Market Value and Consumption Forecast (2020-2025)
14.3.2 Europe Market Value and Consumption Forecast (2020-2025)
14.3.3 Asia Pacific Market Value and Consumption Forecast (2020-2025)
14.3.4 Middle East and Africa Market Value and Consumption Forecast (2020-2025)
14.3.5 South America Market Value and Consumption Forecast (2020-2025)
15 New Project Feasibility Analysis15.1 Industry Barriers and New Entrants SWOT Analysis
15.1.1 Porter’s Five Forces Analysis
15.1.2 New Entrants SWOT Analysis15.2 Analysis and Suggestions on New Project Investment
List of Tables and Figures
Figure Product Picture of Active Pharmaceutical Ingredients (API)
Table Product Specification of Active Pharmaceutical Ingredients (API)
Table Active Pharmaceutical Ingredients (API) Key Market Segments
Table Key Players Active Pharmaceutical Ingredients (API) Covered
Figure Global Active Pharmaceutical Ingredients (API) Market Size, 2015 – 2025
Table Different Types of Active Pharmaceutical Ingredients (API)
Figure Global Active Pharmaceutical Ingredients (API) Value ($) Segment by Type from 2015-2020
Figure Global Active Pharmaceutical Ingredients (API) Market Share by Types in 2019
Table Different Applications of Active Pharmaceutical Ingredients (API)
Figure Global Active Pharmaceutical Ingredients (API) Value ($) Segment by Applications from 2015-2020
Figure Global Active Pharmaceutical Ingredients (API) Market Share by Applications in 2019
Figure Global Active Pharmaceutical Ingredients (API) Market Share by Regions in 2019
Figure North America Active Pharmaceutical Ingredients (API) Production Value ($) and Growth Rate (2015-2020)
Figure Europe Active Pharmaceutical Ingredients (API) Production Value ($) and Growth Rate (2015-2020)
Figure Asia Pacific Active Pharmaceutical Ingredients (API) Production Value ($) and Growth Rate (2015-2020)
Figure Middle East and Africa Active Pharmaceutical Ingredients (API) Production Value ($) and Growth Rate (2015-2020)
Figure South America Active Pharmaceutical Ingredients (API) Production Value ($) and Growth Rate (2015-2020)
Table Global COVID-19 Status and Economic Overview
Figure Global COVID-19 Status
Figure COVID-19 Comparison of Major Countries
Figure Industry Chain Analysis of Active Pharmaceutical Ingredients (API)
Table Upstream Raw Material Suppliers of Active Pharmaceutical Ingredients (API) with Contact Information
Table Major Players Headquarters, and Service Area of Active Pharmaceutical Ingredients (API)
Figure Major Players Production Value Market Share of Active Pharmaceutical Ingredients (API) in 2019
Table Major Players Active Pharmaceutical Ingredients (API) Product Types in 2019
Figure Production Process of Active Pharmaceutical Ingredients (API)
Figure Manufacturing Cost Structure of Active Pharmaceutical Ingredients (API)
Figure Channel Status of Active Pharmaceutical Ingredients (API)
Table Major Distributors of Active Pharmaceutical Ingredients (API) with Contact Information
Table Major Downstream Buyers of Active Pharmaceutical Ingredients (API) with Contact Information
Table Global Active Pharmaceutical Ingredients (API) Value ($) by Type (2015-2020)
Table Global Active Pharmaceutical Ingredients (API) Value Share by Type (2015-2020)
Figure Global Active Pharmaceutical Ingredients (API) Value Share by Type (2015-2020)
Table Global Active Pharmaceutical Ingredients (API) Production by Type (2015-2020)
Table Global Active Pharmaceutical Ingredients (API) Production Share by Type (2015-2020)
Figure Global Active Pharmaceutical Ingredients (API) Production Share by Type (2015-2020)
Figure Global Active Pharmaceutical Ingredients (API) Value ($) and Growth Rate of Synthetic Chemical API (2015-2020)
Figure Global Active Pharmaceutical Ingredients (API) Value ($) and Growth Rate of Biological API (2015-2020)
Figure Global Active Pharmaceutical Ingredients (API) Price by Type (2015-2020)
Figure Downstream Market Overview
Table Global Active Pharmaceutical Ingredients (API) Consumption by Application (2015-2020)
Table Global Active Pharmaceutical Ingredients (API) Consumption Market Share by Application (2015-2020)
Figure Global Active Pharmaceutical Ingredients (API) Consumption Market Share by Application (2015-2020)
Figure Global Active Pharmaceutical Ingredients (API) Consumption and Growth Rate of Anti-infectives (2015-2020)
Figure Global Active Pharmaceutical Ingredients (API) Consumption and Growth Rate of Oncology (2015-2020)
Figure Global Active Pharmaceutical Ingredients (API) Consumption and Growth Rate of Cardiovascular and hematopoietic system (2015-2020)
Figure Global Active Pharmaceutical Ingredients (API) Consumption and Growth Rate of Central nervous system (2015-2020)
Figure Global Active Pharmaceutical Ingredients (API) Consumption and Growth Rate of Respiratory system (2015-2020)
Figure Global Active Pharmaceutical Ingredients (API) Consumption and Growth Rate of Gastrointestinal (2015-2020)
Figure Global Active Pharmaceutical Ingredients (API) Consumption and Growth Rate of Hormonal related disorders (2015-2020)
Figure Global Active Pharmaceutical Ingredients (API) Consumption and Growth Rate of Metabolic disorders (2015-2020)
Figure Global Active Pharmaceutical Ingredients (API) Consumption and Growth Rate of Genito-urinary disorders (2015-2020)
Figure Global Active Pharmaceutical Ingredients (API) Consumption and Growth Rate of Musculo-skeletal disorders (2015-2020)
Figure Global Active Pharmaceutical Ingredients (API) Consumption and Growth Rate of Other Therapeutics Uses (2015-2020)
Figure Global Active Pharmaceutical Ingredients (API) Sales and Growth Rate (2015-2020)
Figure Global Active Pharmaceutical Ingredients (API) Revenue (M USD) and Growth (2015-2020)
Table Global Active Pharmaceutical Ingredients (API) Sales by Regions (2015-2020)
Table Global Active Pharmaceutical Ingredients (API) Sales Market Share by Regions (2015-2020)
Table Global Active Pharmaceutical Ingredients (API) Revenue (M USD) by Regions (2015-2020)
Table Global Active Pharmaceutical Ingredients (API) Revenue Market Share by Regions (2015-2020)
Table Global Active Pharmaceutical Ingredients (API) Revenue Market Share by Regions in 2015
Table Global Active Pharmaceutical Ingredients (API) Revenue Market Share by Regions in 2019
Figure North America Active Pharmaceutical Ingredients (API) Sales and Growth Rate (2015-2020)
Figure Europe Active Pharmaceutical Ingredients (API) Sales and Growth Rate (2015-2020)
Figure Asia-Pacific Active Pharmaceutical Ingredients (API) Sales and Growth Rate (2015-2020)
Figure Middle East and Africa Active Pharmaceutical Ingredients (API) Sales and Growth Rate (2015-2020)
Figure South America Active Pharmaceutical Ingredients (API) Sales and Growth Rate (2015-2020)
Figure North America COVID-19 Status
Figure North America COVID-19 Confirmed Cases Major Distribution
Figure North America Active Pharmaceutical Ingredients (API) Revenue (M USD) and Growth (2015-2020)
Table North America Active Pharmaceutical Ingredients (API) Sales by Countries (2015-2020)
Table North America Active Pharmaceutical Ingredients (API) Sales Market Share by Countries (2015-2020)
Table North America Active Pharmaceutical Ingredients (API) Revenue (M USD) by Countries (2015-2020)
Table North America Active Pharmaceutical Ingredients (API) Revenue Market Share by Countries (2015-2020)
Figure United States Active Pharmaceutical Ingredients (API) Sales and Growth Rate (2015-2020)
Figure Canada Active Pharmaceutical Ingredients (API) Sales and Growth Rate (2015-2020)
Figure Mexico Active Pharmaceutical Ingredients (API) Sales and Growth (2015-2020)
Figure Europe COVID-19 Status
Figure Europe COVID-19 Confirmed Cases Major Distribution
Figure Europe Active Pharmaceutical Ingredients (API) Revenue (M USD) and Growth (2015-2020)
Table Europe Active Pharmaceutical Ingredients (API) Sales by Countries (2015-2020)
Table Europe Active Pharmaceutical Ingredients (API) Sales Market Share by Countries (2015-2020)
Table Europe Active Pharmaceutical Ingredients (API) Revenue (M USD) by Countries (2015-2020)
Table Europe Active Pharmaceutical Ingredients (API) Revenue Market Share by Countries (2015-2020)
Figure Germany Active Pharmaceutical Ingredients (API) Sales and Growth Rate (2015-2020)
Figure UK Active Pharmaceutical Ingredients (API) Sales and Growth Rate (2015-2020)
Figure France Active Pharmaceutical Ingredients (API) Sales and Growth (2015-2020)
Figure Italy Active Pharmaceutical Ingredients (API) Sales and Growth (2015-2020)
Figure Spain Active Pharmaceutical Ingredients (API) Sales and Growth (2015-2020)
Figure Russia Active Pharmaceutical Ingredients (API) Sales and Growth (2015-2020)
Figure Asia Pacific COVID-19 Status
Figure Asia Pacific Active Pharmaceutical Ingredients (API) Revenue (M USD) and Growth (2015-2020)
Table Asia Pacific Active Pharmaceutical Ingredients (API) Sales by Countries (2015-2020)
Table Asia Pacific Active Pharmaceutical Ingredients (API) Sales Market Share by Countries (2015-2020)
Table Asia Pacific Active Pharmaceutical Ingredients (API) Revenue (M USD) by Countries (2015-2020)
Table Asia Pacific Active Pharmaceutical Ingredients (API) Revenue Market Share by Countries (2015-2020)
Figure China Active Pharmaceutical Ingredients (API) Sales and Growth Rate (2015-2020)
Figure Japan Active Pharmaceutical Ingredients (API) Sales and Growth Rate (2015-2020)
Figure South Korea Active Pharmaceutical Ingredients (API) Sales and Growth (2015-2020)
Figure India Active Pharmaceutical Ingredients (API) Sales and Growth (2015-2020)
Figure Southeast Asia Active Pharmaceutical Ingredients (API) Sales and Growth (2015-2020)
Figure Australia Active Pharmaceutical Ingredients (API) Sales and Growth (2015-2020)
Figure Middle East Active Pharmaceutical Ingredients (API) Revenue (M USD) and Growth (2015-2020)
Table Middle East Active Pharmaceutical Ingredients (API) Sales by Countries (2015-2020)
Table Middle East and Africa Active Pharmaceutical Ingredients (API) Sales Market Share by Countries (2015-2020)
Table Middle East and Africa Active Pharmaceutical Ingredients (API) Revenue (M USD) by Countries (2015-2020)
Table Middle East and Africa Active Pharmaceutical Ingredients (API) Revenue Market Share by Countries (2015-2020)
Figure Saudi Arabia Active Pharmaceutical Ingredients (API) Sales and Growth Rate (2015-2020)
Figure UAE Active Pharmaceutical Ingredients (API) Sales and Growth Rate (2015-2020)
Figure Egypt Active Pharmaceutical Ingredients (API) Sales and Growth (2015-2020)
Figure Nigeria Active Pharmaceutical Ingredients (API) Sales and Growth (2015-2020)
Figure South Africa Active Pharmaceutical Ingredients (API) Sales and Growth (2015-2020)
Figure South America Active Pharmaceutical Ingredients (API) Revenue (M USD) and Growth (2015-2020)
Table South America Active Pharmaceutical Ingredients (API) Sales by Countries (2015-2020)
Table South America Active Pharmaceutical Ingredients (API) Sales Market Share by Countries (2015-2020)
Table South America Active Pharmaceutical Ingredients (API) Revenue (M USD) by Countries (2015-2020)
Table South America Active Pharmaceutical Ingredients (API) Revenue Market Share by Countries (2015-2020)
Figure Brazil Active Pharmaceutical Ingredients (API) Sales and Growth Rate (2015-2020)
Figure Argentina Active Pharmaceutical Ingredients (API) Sales and Growth Rate (2015-2020)
Figure Columbia Active Pharmaceutical Ingredients (API) Sales and Growth (2015-2020)
Figure Chile Active Pharmaceutical Ingredients (API) Sales and Growth (2015-2020)
Figure Top 3 Market Share of Active Pharmaceutical Ingredients (API) Companies in 2019
Figure Top 6 Market Share of Active Pharmaceutical Ingredients (API) Companies in 2019
Table Major Players Production Value ($) Share (2015-2020)
Table Teva Pharmaceutical Industries LTD Profile
Table Teva Pharmaceutical Industries LTD Product Introduction
Figure Teva Pharmaceutical Industries LTD Production and Growth Rate
Figure Teva Pharmaceutical Industries LTD Value ($) Market Share 2015-2020
Table BASF SE Profile
Table BASF SE Product Introduction
Figure BASF SE Production and Growth Rate
Figure BASF SE Value ($) Market Share 2015-2020
Table Pfizer, Inc. Profile
Table Pfizer, Inc. Product Introduction
Figure Pfizer, Inc. Production and Growth Rate
Figure Pfizer, Inc. Value ($) Market Share 2015-2020
Table Dr. Reddy's Laboratories Profile
Table Dr. Reddy's Laboratories Product Introduction
Figure Dr. Reddy's Laboratories Production and Growth Rate
Figure Dr. Reddy's Laboratories Value ($) Market Share 2015-2020
Table Mylan N.V. Profile
Table Mylan N.V. Product Introduction
Figure Mylan N.V. Production and Growth Rate
Figure Mylan N.V. Value ($) Market Share 2015-2020
Table Boehringer Ingelheim GmbH Profile
Table Boehringer Ingelheim GmbH Product Introduction
Figure Boehringer Ingelheim GmbH Production and Growth Rate
Figure Boehringer Ingelheim GmbH Value ($) Market Share 2015-2020
Table Albemarle Corporation Profile
Table Albemarle Corporation Product Introduction
Figure Albemarle Corporation Production and Growth Rate
Figure Albemarle Corporation Value ($) Market Share 2015-2020
Table Hospira Inc. Profile
Table Hospira Inc. Product Introduction
Figure Hospira Inc. Production and Growth Rate
Figure Hospira Inc. Value ($) Market Share 2015-2020
Table Lonza Group Profile
Table Lonza Group Product Introduction
Figure Lonza Group Production and Growth Rate
Figure Lonza Group Value ($) Market Share 2015-2020
Table Actavis plc Profile
Table Actavis plc Product Introduction
Figure Actavis plc Production and Growth Rate
Figure Actavis plc Value ($) Market Share 2015-2020
Table Lupin Pharmaceuticals Inc. Profile
Table Lupin Pharmaceuticals Inc. Product Introduction
Figure Lupin Pharmaceuticals Inc. Production and Growth Rate
Figure Lupin Pharmaceuticals Inc. Value ($) Market Share 2015-2020
Table Novartis AG Profile
Table Novartis AG Product Introduction
Figure Novartis AG Production and Growth Rate
Figure Novartis AG Value ($) Market Share 2015-2020
Table Aurobindo Pharma Limited Profile
Table Aurobindo Pharma Limited Product Introduction
Figure Aurobindo Pharma Limited Production and Growth Rate
Figure Aurobindo Pharma Limited Value ($) Market Share 2015-2020
Table Sun Pharmaceutical Industries LTD Profile
Table Sun Pharmaceutical Industries LTD Product Introduction
Figure Sun Pharmaceutical Industries LTD Production and Growth Rate
Figure Sun Pharmaceutical Industries LTD Value ($) Market Share 2015-2020
Table Fresenius Kabi Profile
Table Fresenius Kabi Product Introduction
Figure Fresenius Kabi Production and Growth Rate
Figure Fresenius Kabi Value ($) Market Share 2015-2020
Table Market Driving Factors of Active Pharmaceutical Ingredients (API)
Table Merger, Acquisition and New Investment
Table Global Active Pharmaceutical Ingredients (API) Market Value ($) Forecast, by Type
Table Global Active Pharmaceutical Ingredients (API) Market Volume Forecast, by Type
Figure Global Active Pharmaceutical Ingredients (API) Market Value ($) and Growth Rate Forecast of Synthetic Chemical API (2020-2025)
Figure Global Active Pharmaceutical Ingredients (API) Market Volume ($) and Growth Rate Forecast of Synthetic Chemical API (2020-2025)
Figure Global Active Pharmaceutical Ingredients (API) Market Value ($) and Growth Rate Forecast of Biological API (2020-2025)
Figure Global Active Pharmaceutical Ingredients (API) Market Volume ($) and Growth Rate Forecast of Biological API (2020-2025)
Table Global Market Value ($) Forecast by Application (2020-2025)
Table Global Market Volume Forecast by Application (2020-2025)
Figure Market Value ($) and Growth Rate Forecast of Anti-infectives (2020-2025)
Figure Market Volume and Growth Rate Forecast of Anti-infectives (2020-2025)
Figure Market Value ($) and Growth Rate Forecast of Oncology (2020-2025)
Figure Market Volume and Growth Rate Forecast of Oncology (2020-2025)
Figure Market Value ($) and Growth Rate Forecast of Cardiovascular and hematopoietic system (2020-2025)
Figure Market Volume and Growth Rate Forecast of Cardiovascular and hematopoietic system (2020-2025)
Figure Market Value ($) and Growth Rate Forecast of Central nervous system (2020-2025)
Figure Market Volume and Growth Rate Forecast of Central nervous system (2020-2025)
Figure Market Value ($) and Growth Rate Forecast of Respiratory system (2020-2025)
Figure Market Volume and Growth Rate Forecast of Respiratory system (2020-2025)
Figure Market Value ($) and Growth Rate Forecast of Gastrointestinal (2020-2025)
Figure Market Volume and Growth Rate Forecast of Gastrointestinal (2020-2025)
Figure Market Value ($) and Growth Rate Forecast of Hormonal related disorders (2020-2025)
Figure Market Volume and Growth Rate Forecast of Hormonal related disorders (2020-2025)
Figure Market Value ($) and Growth Rate Forecast of Metabolic disorders (2020-2025)
Figure Market Volume and Growth Rate Forecast of Metabolic disorders (2020-2025)
Figure Market Value ($) and Growth Rate Forecast of Genito-urinary disorders (2020-2025)
Figure Market Volume and Growth Rate Forecast of Genito-urinary disorders (2020-2025)
Figure Market Value ($) and Growth Rate Forecast of Musculo-skeletal disorders (2020-2025)
Figure Market Volume and Growth Rate Forecast of Musculo-skeletal disorders (2020-2025)
Figure Market Value ($) and Growth Rate Forecast of Other Therapeutics Uses (2020-2025)
Figure Market Volume and Growth Rate Forecast of Other Therapeutics Uses (2020-2025)
Figure North America Market Value ($) and Growth Rate Forecast (2020-2025)
Figure North America Consumption and Growth Rate Forecast (2020-2025)
Figure Europe Market Value ($) and Growth Rate Forecast (2020-2025)
Figure Europe Consumption and Growth Rate Forecast (2020-2025)
Figure Asia Pacific Market Value ($) and Growth Rate Forecast (2020-2025)
Figure Asia Pacific Consumption and Growth Rate Forecast (2020-2025)
Figure Middle East and Africa Market Value ($) and Growth Rate Forecast (2020-2025)
Figure Middle East and Africa Consumption and Growth Rate Forecast (2020-2025)
Figure South America Market Value ($) and Growth Rate Forecast (2020-2025)
Figure South America Consumption and Growth Rate Forecast (2020-2025)
Figure Porter’s Five Forces Analysis
Table New Entrants SWOT Analysis
Table New Project Analysis of Investment Recovery
-
The Global Active Pharmaceutical Ingredients (API) Market has been segregated into various crucial divisions including applications, types, and regions. Each market segment is intensively studied in the report contemplating its market acceptance, worthiness, demand, and growth prospects. The segmentation analysis will help the client to customize their marketing approach to have a better command of each segment and to identify the most prospective customer base.
Report Objectives / Segmentation Covered :
By Companies / players:
By Regions:
By Type:
By Application:
Frequently asked questions(FAQ's):
Companies in the Global Active Pharmaceutical Ingredients (API) Industry will need to adapt swiftly to the behavioral changes that are reshaping consumer decision journeys.
In 2024, the Global Active Pharmaceutical Ingredients (API) Market share surpassed USD xx million, and between 2025 and 2030, it will grow at a CAGR of yy%.
The Global Active Pharmaceutical Ingredients (API) Market research study aids businesses in strategic planning so that they may realize and gain business value from their growth strategies.
Companies in the Global Active Pharmaceutical Ingredients (API) Industry are thoroughly researched and profiled in order to determine why certain trends will have a significant impact and how they will be factored into the Global Active Pharmaceutical Ingredients (API) Market's trajectory and future outlook.
